Basic information
- CAS
101828-21-1- Standard SMILES
CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12- InChIKey
ABJKWBDEJIDSJZ-UHFFFAOYSA-N- Molecular formula
- C23H27N
- Average molar mass
- 317.5 g/mol
- Monoisotopic mass
- 317.21434987
Names & identifiers
- Preferred name
- Butenafine
- IUPAC
- 1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
- English name
- Butenafine
- Molecular formula
- C23H27N
- Molecular weight
- 317.47
Names & synonyms
Show more names
Database identifiers
- CAS
101828-21-1- PubChem CID
- 2484
- DTXSID
DTXSID7040657- ChEMBL
CHEMBL990- ChEBI
CHEBI:3238- UNII
- 91Y494NL0X
- Nikkaji
- J276.436I
Properties
Computed structural properties
- XLogP
- 6.3
- Topological polar surface area
- 3.2 Ų
- Hydrogen bond donors
- 0
- Hydrogen bond acceptors
- 1
- Rotatable bonds
- 5
- Heavy atoms
- 24
- Formal charge
- 0
- Complexity
- 374
Experimental & physicochemical properties
LogP
6.6
6.6
Solubility
Slightly soluble (HCl salt)
7.56e-05 g/L
Physicochemical properties
- Melting point
- 200 · 200-202 °C
- Boiling point
- 426.1 · 426.1±14.0 °C(Predicted)
- Density
- 1.032 · 1.032±0.06 g/cm3(Predicted)
- storage temp.
- -20 °C · Store at -20°C
- solubility
- 63 mg/mL · DMSO: 63 mg/mL (198.44 mM);Ethanol: 63 mg/mL (198.44 mM)
- pka
- 7.87 · 7.87±0.50(Predicted)
- Water Solubility
- Water: Insoluble
- LogP
- 6.77 · 6.770 (est)
- CAS DataBase Reference
- 101828 · 101828-21-1(CAS DataBase Reference)
- FDA UNII
- 91 Y494NL0X · 91Y494NL0X
- ATC code
- 1 AE23 · D01AE23
Safety & regulation
Toxicology
Effects During Pregnancy and Lactation
◉ Summary of Use during Lactation;Topical butenafine has not been studied during breastfeeding. Because it is poorly absorbed after topical application, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. Ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated. Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.;◉ Effects in Breastfed Infants;Relevant published information was not found as of the revision date.;◉ Effects on Lactation and Breastmilk;Relevant published information was not found as of the revision date.
Chemistry & industry
Pharmacology
ATC Code
D - Dermatologicals;D01 - Antifungals for dermatological use;D01A - Antifungals for topical use;D01AE - Other antifungals for topical use;D01AE23 - Butenafine
QD - Dermatologicals;QD01 - Antifungals for dermatological use;QD01A - Antifungals for topical use;QD01AE - Other antifungals for topical use;QD01AE23 - Butenafine
Pharmacodynamics
Butenafine is a synthetic antifungal agent that is structurally and pharmacologically related to allylamine antifungals. The exact mechanism of action has not been established, but it is suggested that butenafine's antifungal activity is exerted through the alteration of cellular membranes, which results in increased membrane permeability, and growth inhibition. Butenafine is mainly active against dermatophytes and has superior fungicidal activity against this group of fungi when compared to that of terbinafine, naftifine, tolnaftate, clotrimazole, and bifonazole. It is also active against <i>Candida albicans</i> and this activity is superior to that of terbinafine and naftifine. Butenafine also generates low MICs for <i>Cryptococcus neoformans</i> and <i>Aspergillus spp.</i> as well.
Mechanism of Action
Although the mechanism of action has not been fully established, it has been suggested that butenafine, like allylamines, interferes with sterol biosynthesis (especially ergosterol) by inhibiting squalene monooxygenase, an enzyme responsible for converting squalene to 2,3-oxydo squalene. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Blockage of squalene monooxygenase also leads to a subsequent accumulation of squalene. When a high concentration of squalene is reached, it is thought to have an effect of directly kill fungal cells.
FDA Pharmacological Classification
91Y494NL0X
BUTENAFINE
Established Pharmacologic Class [EPC] - Benzylamine Antifungal
Chemical Structure [CS] - Benzylamines
Butenafine is a Benzylamine Antifungal.
Applications
UsesButenafine (Mentax) is a synthetic benzylamine antifungal agent, related structurally and pharmacologically to terbinafine. It is thought to act by inhibiting the enzyme squalene 2,3-epoxidase, resulting in decreased ergosterol and corresponding increase in squalene, with subsequent cell membrane permeability alteration and cell death. It is active against dermatophytes, yeast, and Sporothrix.
Preparation methods
Preparation1. Using 1-naphthoic acid as a raw material, chlorination with thionyl chloride yields 1-naphthoyl chloride, which is then condensed with 1-(4-tert-butylbenzyl)-N-methylmethylamine to give N-(4-tert-butylbenzyl)-N-methyl-1-naphthoamide. This is followed by reduction with lithium aluminum hydride and salt formation to obtain butenafine hydrochloride. 2. Using p-tert-butylbenzoic acid as a raw material, chlorination with thionyl chloride yields p-tert-butylbenzoyl chloride, which is then condensed with N-methylnaphthylmethylamine to give 4-tert-butyl-N-methyl-N-(methylnaphthyl)benzamide. This is followed by reduction with lithium aluminum hydride and salt formation to obtain butenafine hydrochloride. 3. Using naphthalene as a raw material, chloromethylation synthesizes 1-chloromethylnaphthalene, which then reacts with methylamine to generate N-methylnaphthylmethylamine. This is followed by condensation with p-tert-butylbenzyl chloride and salt formation to obtain butenafine hydrochloride. 4. Starting with naphthalene, 1-chloromethylnaphthalene was prepared by chloromethylation, and then substituted with methylamine to obtain the key intermediate N-methyl-1-naphthylmethylamine hydrochloride. This was then condensed with p-tert-butylbenzyl chloride, followed by salt formation and recrystallization to obtain butenafine hydrochloride. 5. N-methyl-1-naphthylmethylamine hydrochloride (2) (41.5 g, 0.20 mol) was added to a mixture of toluene (150 ml) and 10% sodium hydroxide solution (160 g). The mixture was heated to 80 °C, and p-tert-butylbenzyl chloride (3) (40.2 g, 0.22 mol) was added dropwise with stirring over approximately 1 hour. The reaction was continued with stirring for 3 hours. The reaction was stopped, and the organic layer was separated after cooling to room temperature. The organic layer was washed with water until neutral and dried with anhydrous sodium sulfate. After filtration, the toluene was recovered, and the residue was dissolved in an appropriate amount of ethanol. The pH was adjusted to 2 with concentrated hydrochloric acid, and the solvent was recovered to obtain a white crude product (59.8 g). Recrystallization with 50% ethanol yields a white, pure product 1.
Suppliers53 total
Additional notes
DefinitionChEBI: Trimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in funga cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections.
Related reactions
Compound notes
Loading…